New YorkEnacts the "New York affordable drug manufacturing act"
What it does
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Feb 24REFERRED TO HEALTHLatest
- Vote recorded Floor Vote. Result: pass.Upper
- Feb 24DELIVERED TO ASSEMBLY
- Feb 24PASSED SENATEPassed 2nd Chamber
- Feb 9ORDERED TO THIRD READING CAL.293
- Vote recorded Rules Vote. Result: pass.Upper
- Feb 9COMMITTEE DISCHARGED AND COMMITTED TO RULESMinor
- Feb 4REPORTED AND COMMITTED TO FINANCEMinor
- Vote recorded Health Vote. Result: pass.Upper
- Jan 7REFERRED TO HEALTHMinor
- Jan 7RETURNED TO SENATE
- Jan 7DIED IN ASSEMBLY
- Feb 24REFERRED TO HEALTHLatest
- 2025
- May 20REFERRED TO HEALTHMinor
- Vote recorded Floor Vote. Result: pass.Upper
- May 20DELIVERED TO ASSEMBLY
- May 20PASSED SENATEPassed 1st Chamber
- May 1ADVANCED TO THIRD READING
- Apr 302ND REPORT CAL.
- Apr 291ST REPORT CAL.750
- Vote recorded Finance Vote. Result: pass.Upper
- Jan 21REPORTED AND COMMITTED TO FINANCEMinor
- Vote recorded Health Vote. Result: pass.Upper
- Jan 13REFERRED TO HEALTHIntroduced
- May 20REFERRED TO HEALTHMinor